BIOAF Stock Price, Chart, Stats & News

Bioasis Technologies Inc. is a developing biopharmaceutical enterprise dedicated to the discovery and advancement of treatments and diagnostic tools for various neurological conditions. Central to its strategy is the proprietary xB3 platform, an innovative technology designed to overcome the blood-brain barrier (BBB) and effectively deliver therapeutic agents to the central nervous system (CNS). This platform targets a range of CNS disorders, including brain cancers, metabolic illnesses, and neurodegenerative diseases.